Federal Appeal


Civil Procedure

COSTS
Not immutable principle of law that no costs awarded where success divided

Appeal from judgment awarding respondents costs of $45,000. Judgment disposed of application under Patented Medicines (Notice of Compliance) Regulations (Can.), for order prohibiting appellant from selling certain drug until expiry of two patents. Application judge awarded respondents 50% of costs claimed. Appeal dismissed. Decision on costs was discretionary and would not be disturbed on appeal unless decision was based on error in principle or was plainly wrong. Where success was divided, it was not immutable principle of law that no costs would be awarded. Application judge was clearly aware of practical result of proceeding and remedies sought.

Mylan Pharmaceuticals ULC v. Bristol-Myers Squibb Canada Co. (Oct. 1, 2013, F.C.A., K. Sharlow J.A., Mainville J.A., and Near J.A., File No. A-74-13) 234 A.C.W.S. (3d) 560.

cover image

DIGITAL EDITION

Subscribers get early and easy access to Law Times.

Professional Development


Law Times Poll


A Law Times column argues it’s time for provincial laws dedicated to stopping defamatory publications on the Internet. Do you think that new legislation will help counter defamatory statements online?
RESULTS ❯